D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.61% |
| 2 | Healthcare | 10.26% |
| 3 | Consumer Discretionary | 10.07% |
| 4 | Financials | 8.17% |
| 5 | Communication Services | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Lineage Cell Therapeutics
LCTX
$257M
| $324K | ﹤0.01% |
130,356
+47,513
| +57% | +$118K |
|
|
SKX
3077
DELISTED
Skechers
SKX
| $323K | ﹤0.01% |
+12,868
| New | +$351K |
|
3078
Talphera
TLPH
$70.1M
| $322K | ﹤0.01% |
3,497
-2,308
| -40% | -$144K |
|
3079
ESCO Technologies
ESE
$8.49B
| $320K | ﹤0.01% |
5,332
-579
| -10% | -$33.4K |
|
3080
Ball Corp
BALL
$17B
| $319K | ﹤0.01% |
+7,728
| New | +$317K |
|
3081
PUT
Icon
ICLR
$12.8B
| $319K | ﹤0.01% |
+2,800
| New | +$298K |
|
3082
VEON
VEON
$3.53B
| $319K | ﹤0.01% |
3,056
+2,197
| +256% | +$224K |
|
3083
Commercial Vehicle Group
CVGI
$157M
| $317K | ﹤0.01% |
43,145
+4,372
| +11% | +$31.9K |
|
3084
NewtekOne
NEWT
$417M
| $317K | ﹤0.01% |
17,775
+5,208
| +41% | +$89K |
|
3085
Village Super Market
VLGEA
$631M
| $316K | ﹤0.01% |
12,768
+421
| +3% | +$10.1K |
|
3086
Essex Property Trust
ESS
$18.9B
| $315K | ﹤0.01% |
1,241
| – | – |
|
3087
Aclaris Therapeutics
ACRS
$730M
| $314K | ﹤0.01% |
+12,158
| New | +$326K |
|
3088
Empire State Realty Trust
ESRT
$976M
| $314K | ﹤0.01% |
+15,303
| New | +$313K |
|
3089
Regenxbio
RGNX
$623M
| $314K | ﹤0.01% |
+9,516
| New | +$214K |
|
|
I
3090
DELISTED
INTELSAT S. A.
I
| $314K | ﹤0.01% |
66,774
+9,232
| +16% | +$34.9K |
|
3091
Standard Motor Products
SMP
$861M
| $312K | ﹤0.01% |
6,462
-13,936
| -68% | -$665K |
|
|
LTC
3092
LTC Properties
LTC
$2.16B
| $311K | ﹤0.01% |
6,618
+924
| +16% | +$45.5K |
|
|
SLCA
3093
CALL
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $311K | ﹤0.01% |
10,000
| – | – |
|
|
SJR
3094
DELISTED
Shaw Communications Inc.
SJR
| $311K | ﹤0.01% |
13,500
-1,750
| -11% | -$38.9K |
|
3095
CALL
3D Systems Corp
DDD
$420M
| $308K | ﹤0.01% |
23,000
-7,200
| -24% | -$105K |
|
|
ORIT
3096
DELISTED
Oritani Financial Corp. New
ORIT
| $308K | ﹤0.01% |
18,349
+2,067
| +13% | +$34K |
|
|
CADE
3097
DELISTED
Cadence Bank
CADE
| $307K | ﹤0.01% |
9,580
-20,817
| -68% | -$623K |
|
|
GCP
3098
CALL
DELISTED
GCP Applied Technologies Inc.
GCP
| $307K | ﹤0.01% |
10,000
| – | – |
|
3099
Celldex Therapeutics
CLDX
$2.77B
| $306K | ﹤0.01% |
7,147
+5,910
| +478% | +$222K |
|
3100
PUT
Brinker International
EAT
$8.02B
| $306K | ﹤0.01% |
+9,600
| New | +$327K |
|
Similar funds
D.E. Shaw & Co's Q3 2017 Portfolio in Review
As of Q3 2017, D.E. Shaw & Co held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
D.E. Shaw & Co's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- D.E. Shaw & Co added most to Comcast in Q3 2017, an estimated $354M increase.
- D.E. Shaw & Co's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- D.E. Shaw & Co fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- D.E. Shaw & Co's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- D.E. Shaw & Co opened 469 new positions and closed 370 in Q3 2017.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.